Maheshwara R. Appannan
Complex F, 62000, Malaysia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Nirmatrelvir/ritonavir treatment and the risk of post-COVID condition over 180 days in Malaysia.
Journal: BMC infectious diseases
Published: May 31, 2024
Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence Perspective.
Journal: Drugs - real world outcomes
Published: April 23, 2024
Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 06, 2023
Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
Journal: JAMA network open
Published: August 10, 2022
Estimating the infection burden of COVID-19 in Malaysia.
Journal: PLoS neglected tropical diseases
Published: February 07, 2022
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 03, 2022
Spatial Dynamics and Multiscale Regression Modelling of Population Level Indicators for COVID-19 Spread in Malaysia.
Journal: International journal of environmental research and public health
Published: January 06, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026